MBD2, a type of MBD protein, is thought to have a protective role against bladder cancer as demonstrated by Zhu et al., whose 2004 study reported that high expression of MBD2 is associated with a reduced risk of urothelial carcinoma [53]. This evidence concerns the gene MBD2 and urothelial carcinoma.